IL17A and neoplasm: In the tumor microenvironment (TME), tumor-induced Foxp3-negative IL-17A+ Th17 cells decline in number at later time points, concomitant with the increase of “ex-Th17” Foxp3+IL-17A- suppressive tumor-associated Tregs (41).